Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ImmuCell Corporation
ICCC | US
7.73
USD0.62
8.72%
ICCC | US
About ImmuCell Corporation
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
14/04/2026
Close
7.73
Open
7.28
High
7.82
Low
7.28
ImmuCell Corporation an animal health company develops manufactures and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense a passive antibody product for the treatment of E. coli coronavirus and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk as well as to determine which quarter of the udder is mastitic; and Dual-Force First Defense including a whey protein concentrate for the nutritional and feed supplement markets. In addition it is involved in developing Re-Tain a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland Maine.
View LessICCC | US
Risk
62.5
Sharpe
0.80
Luna's Score
64/100
Recommendation
Hold
Luna says (ICCC | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
79.2%1 month
62.5%3 months
51.3%6 months
54.4%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.23
Debt to equity
0.68
Debt to assets
0.38
Ent. to EBITDA
-21.19
Ent. to rev.
1.87
PEG
-
Other Fundamentals
EBITDA
-633.70K
MarketCap
60.55M
MarketCap(USD)
60.55M
Div. yield
-
Op. margin
-25.34
Erngs. growth
-63.40
Rev. growth
54.90
Ret. on equity
-16.10
Short ratio
0.20
Short perc.
0.18
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
1.57
Range1M
1.82
Range3M
2.07
Volumes: Market Activity
Rel. volume
3.57
Price X volume
625.06K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -21.19 | - | Cheaper |
| Ent. to Revenue | 1.87 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.23 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 51.26 | - | Lower Risk |
| Debt to Equity | 0.68 | -1.23 | Expensive |
| Debt to Assets | 0.38 | 0.25 | Expensive |
| Market Cap | 60.55M | - | Emerging |
